These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 25271350)

  • 1. [Hepatitis C: a study predicts a costly future if nothing is done now].
    Perreault D
    Perspect Infirm; 2014; 11(4):14. PubMed ID: 25271350
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis C: What lies ahead and can we afford it?
    Howie H; Hutchinson SJ
    J Viral Hepat; 2004 Sep; 11 Suppl 1():28-33. PubMed ID: 15357861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of screening for chronic hepatitis C infection in the United States.
    Eckman MH; Talal AH; Gordon SC; Schiff E; Sherman KE
    Clin Infect Dis; 2013 May; 56(10):1382-93. PubMed ID: 23392392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C: the juggernaut rolls on unchecked.
    Sherman M
    Can J Gastroenterol; 2008 Apr; 22(4):355-6. PubMed ID: 18578076
    [No Abstract]   [Full Text] [Related]  

  • 5. Overview of the viral hepatitis problem.
    Lok AS; Kim WR; El-Serag HB; Maddrey WC
    J Fam Pract; 2010 Apr; 59(4 Suppl):S11-6. PubMed ID: 20398585
    [No Abstract]   [Full Text] [Related]  

  • 6. Economic burden of hepatitis C in Canada and the potential impact of prevention. Results from a disease model.
    El Saadany S; Coyle D; Giulivi A; Afzal M
    Eur J Health Econ; 2005 Jun; 6(2):159-65. PubMed ID: 15761777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of direct-acting antiviral therapy in chronic hepatitis C.
    Gellad ZF; Reed SD; Muir AJ
    Antivir Ther; 2012; 17(6 Pt B):1189-99. PubMed ID: 23186646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of timing and prioritization on the cost-effectiveness of birth cohort testing and treatment for hepatitis C virus in the United States.
    McEwan P; Ward T; Yuan Y; Kim R; L'italien G
    Hepatology; 2013 Jul; 58(1):54-64. PubMed ID: 23389841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rising health and economic burden of chronic hepatitis C.
    Montella M; Crispo A; Wynn-Bellezza J; Izzo F; Grimaldi M; Ronga D
    J Hepatol; 2004 Aug; 41(2):353-4; author reply 354-5. PubMed ID: 15288490
    [No Abstract]   [Full Text] [Related]  

  • 10. Direct economic burden of chronic hepatitis C virus in a United States managed care population.
    Davis KL; Mitra D; Medjedovic J; Beam C; Rustgi V
    J Clin Gastroenterol; 2011 Feb; 45(2):e17-24. PubMed ID: 20628308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wanted: an effective public health response to hepatitis C virus in the United States.
    Klein SJ; Flanigan CA; Cooper JG; Holtgrave DR; Carrascal AF; Birkhead GS
    J Public Health Manag Pract; 2008; 14(5):471-5. PubMed ID: 18708891
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic hepatitis C: an age wave of disease burden.
    McHutchison JG; Bacon BR
    Am J Manag Care; 2005 Oct; 11(10 Suppl):S286-95; quiz S307-11. PubMed ID: 16232012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The burden of viral hepatitis in the Russian Federation requires reducing its progression for the long term, including chronic hepatitis C)].
    Iushchuk ND; Znoĭko OO; Iakushechkina NA; Zyrianov SK; Shut'ko SA; Belyĭ PA; Kozina AN; Chapurin SA; Churilin IuIu; Lugovskikh EA
    Ter Arkh; 2013; 85(12):79-85. PubMed ID: 24640674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDC urges universal hepatitis C screening for baby boomers.
    Harv Womens Health Watch; 2012 Aug; 19(12):1, 8. PubMed ID: 23038832
    [No Abstract]   [Full Text] [Related]  

  • 15. Doing battle with HCV.
    Fimmel CJ
    Am J Gastroenterol; 2000 Mar; 95(3):582-3. PubMed ID: 10710043
    [No Abstract]   [Full Text] [Related]  

  • 16. Under the radar: why hepatitis C is so hard to control.
    Am J Manag Care; 2007 Dec; 13 Suppl 12():S316-8. PubMed ID: 18188881
    [No Abstract]   [Full Text] [Related]  

  • 17. CDC and USPSTF 2012 recommendations for screening for hepatitis C virus infection: overview and take-home messages.
    Kanwal F; Lok AS; El-Serag HB
    Clin Gastroenterol Hepatol; 2013 Mar; 11(3):200-3. PubMed ID: 23432900
    [No Abstract]   [Full Text] [Related]  

  • 18. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States.
    Arguedas MR; Heudebert GR; Fallon MB; Stinnett AA
    Am J Gastroenterol; 2002 Mar; 97(3):721-8. PubMed ID: 11922569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding hepatitis C infection.
    Tecnologica; 1998 Oct; ():1, 3-6, 15. PubMed ID: 10343048
    [No Abstract]   [Full Text] [Related]  

  • 20. Estimating the cost-effectiveness of detecting cases of chronic hepatitis C infection on reception into prison.
    Sutton AJ; Edmunds WJ; Gill ON
    BMC Public Health; 2006 Jun; 6():170. PubMed ID: 16803622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.